TEAMIT RESEARCH SL
- Country
- Spain
- Type
- Beneficiary
- Grants received
- 14
Funding record
- 14 grants on record
- €8,578,660.89 awarded in total
- 2017–2026 years covered
This total adds up only the grants our sources publish. It is not the total funding this organisation has received.
Programmes
6 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations funded alongside this one on two or more projects. Sharing a single project does not count. Some projects have as many as 195 participants, and appearing on the same list once is not a working relationship.
- JANSSEN PHARMACEUTICA NV
- ASTRAZENECA AB
- KATHOLIEKE UNIVERSITEIT LEUVEN
- NOVARTIS PHARMA AG
- EATRIS ERIC
- FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
- BAYER AKTIENGESELLSCHAFT
Calls from this organisation
No published calls from this organisation.
Grants received
- European Pediatric Immunotherapy Trial with Combinatory ATMPs for DIPG
- FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
- Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases
- Unleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome Prediction
- EUROPEAN RARE DISEASES RESEARCH ALLIANCE
- Widening Synergies for Novel Enzymes Development
- Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases
- BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
- Preparing for RSV Immunisation and Surveillance in Europe
- H2O Health Outcomes Observatory
- Prioritisation and Risk Evaluation of Medicines in the EnviRonment
- EU Patient- cEntric clinicAl tRial pLatform
- Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
- REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
We collected this from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.